FullCircle Wealth’s IGC Pharma IGC Stock Holding History

FullCircle Wealth’s Portfolio IGC Stock Details IGC Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2024 Q4	–	Sell	-103,443	Closed	-$41.9K	–	230
2024 Q3	$41.9K	Buy	+103,443	New	+$41.5K	0.02%	186

Other funds holding IGC

BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return

Geode Capital Management Boston, Massachusetts $1.61T AUM 30.72% 1-Year Est. Return

Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return

State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return

Squarepoint New York $85.1B AUM 20.93% 1-Year Est. Return

Northern Trust Chicago, Illinois $757B AUM 28.64% 1-Year Est. Return

Dearborn Partners Chicago, Illinois $1.85B AUM 6.59% 1-Year Est. Return

Goldman Sachs New York $871B AUM 31.28% 1-Year Est. Return

TSS

Two Sigma Securities New York $861M AUM 21.33% 1-Year Est. Return

Truist Financial Charlotte, North Carolina $74.2B AUM 21.09% 1-Year Est. Return

FullCircle Wealth's IGC Position: Q4 2024 in Review

FullCircle Wealth sold out of IGC Pharma (IGC) in Q4 2024, closing a stake of 103,443 shares — an estimated $41.9K sold.

FullCircle Wealth first reported a position in IGC in Q3 2024 and held it in 1 quarter. The position peaked at $41.9K in Q3 2024. 30 funds tracked by Wall St. Rank hold IGC as of Q4 2024.

FullCircle Wealth reported no remaining IGC Pharma position as of Q4 2024 after selling out during the quarter.
FullCircle Wealth sold 103,443 IGC Pharma shares in Q4 2024, an estimated $41.9K.
FullCircle Wealth first reported a position in IGC Pharma in Q3 2024 and held it in 1 quarter.
FullCircle Wealth's IGC Pharma position peaked at $41.9K in Q3 2024.
30 funds tracked by Wall St. Rank held IGC Pharma as of Q4 2024.

Based on FullCircle Wealth's 13F filing for Q4 2024, filed 14 Feb 2025.